Loading company…
Waterstone, founded in 2009 in Wuhan, develops molecular medicines and active pharmaceutical ingredients.
Established in 2009 and based in Wuhan, China, Waterstone is a biotechnology medicine company focused on molecular medicine and new drugs. It holds more than 30 invention patents authorized by China, the United States and Japan. Founder and chairman Faming Zhang is a professor at the School of Pharmacy, Wuhan University. Its products target cancer, NASH, diabetes and kidney disease, including Alogliptin Benzoate, Canagliflozin and Febuxostat. In November 2020 it raised CNY 100 million in Series C+ funding.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in